Has Ashok Salvi, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,765 in general payments to Ashok Salvi, MD across 91 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ashok Salvi, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ashok Salvi, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ashok Salvi, MD

Interventional Pain Medicine · Toledo, OHNPI 1740287424

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 91 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $342 and has fallen 50.1% since, to $170 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OH, where the typical reported total is $5,193.

$1,765in general payments, 2019–2025

Across 91 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$231
Vertos Medical, Inc.$185
Nevro Corp.$171
Si-bone, Inc.$161
Pfizer$116
Boston Scientific$94
plus $807 from 23 others

What the payments were for

Food & beverage$1,765100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	15	$231
Vertos Medical, Inc.	4	$185
Nevro Corp.	8	$171
Si-bone, Inc.	2	$161
Pfizer	10	$116
Boston Scientific	5	$94
AbbVie(2 entities)	6	$87
Vertex	4	$73
Novartis	2	$65
Biodelivery Sciences International, Inc.	4	$54
Relievant Medsystems, Inc.	3	$50
Amgen	2	$45
Medtronic(2 entities)	3	$43
GRT US Holding, Inc.	2	$34
Abbott	2	$34
Scilex Pharmaceuticals Inc.	2	$33
Protega Pharmaceutials Inc	2	$33
Globus Medical	2	$32
Averitas Pharma Inc.	1	$31
Collegium Pharmaceutical, Inc.	2	$29
Virtus Pharmaceuticals LLC	2	$27
Stryker	1	$24
Valinor Pharma, LLC	1	$21
Nalu Medical, Inc.	1	$20
Kowa Pharmaceuticals America, Inc.	1	$18
Arbor Pharmaceuticals, Inc.	1	$16
Daiichi Sankyo Inc.	1	$14
Almatica Pharma LLC	1	$12
Vertical Pharmaceuticals, LLC	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

iFuse Implant$146

How this compares

$1,765 in reported general payments places this provider in the 20th percentile of 67 interventional pain medicine providers in Ohio.

See all interventional pain medicine providers in Ohio →

Medicare billing

Part B allowed, 2024

$115,497

Medicare patients

224

Services billed

3,797

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diazepam	17	$5

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Toledo

James OttingToledo$47K
Nadeem MoghalToledo$17K
William JamesToledo$14K
Amar GoyalToledo$7K
Muhammad HefzyToledo$1K
Gladstone McDowellColumbus$660K
Humam AkbikFairfield$116K
Sara NashiCincinnati$116K
Jaudat MahmoodKent$97K
Omar AliSpringfield$67K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →